WuXi AppTec | Leading Global CRDMO (original) (raw)
Foster Collaboration with Innovative Solutions
An Integrated CRDMO Business Model
Supporting our customers to deliver groundbreaking treatments to patients around the world
News
Latest News about WuXi AppTec
WuXi AppTec’s Changzhou and Taixing API Sites Successfully Pass FDA Inspections
WuXi AppTec Revenue and Profit Achieved Steady QoQ Growth in 2024, Meeting Full-year Guidance; Q4 Revenue and Profit Both Reached Record Highs
WuXi AppTec Recognized as an Industry and Regional ESG Top-Rated Company by Morningstar Sustainalytics for the Third Consecutive Year
WuXi AppTec Joins the Pharmaceutical Supply Chain Initiative (PSCI)
WuXi AppTec Listed in TIME Magazine's World's Best Companies in Sustainable Growth 2025